Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Conditions: Chronic Kidney Diseases; Diabetes Mellitus; Diabetic Nephropathies
Interventions: Dietary Supplement: Fisetin; Drug: Placebo oral capsule
Sponsors: Mayo Clinic
Suspended

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments